Skip to content

Plain-English explainer

Noom Semaglutide Review (2026): Noom Med, Cost & Is It Legit?

Explained by Sofia Mendez, Patient Education Editor

We keep this plain-English — no jargon, every claim sourced.

If you searched "Noom semaglutide," you likely already know Noom as the psychology-based weight-loss app and are wondering whether its medication arm — marketed as Noom Med — is a sensible way to get a GLP-1. The honest summary: Noom is a legitimate company whose core product is behavior-change coaching, and Noom Med layers a clinician and prescription GLP-1 medication on top of that app for eligible members. Its genuine differentiator is the coaching DNA — Noom's whole identity is the behavioral side, which the evidence says actually matters for GLP-1 outcomes. Whether it's worth it depends on what medication you get, the all-in cost, and whether you value the app. This review covers what Noom Med is, the cost, common reports, and the honest catch — all as of June 2026. Verify current pricing and terms directly; nothing here is medical or financial advice, and we earn nothing by steering you to any program.

Quick answer: is Noom legit?

Quick answer

Yes — Noom is a large, well-known, legitimate company, and Noom Med is a real clinician-supervised medication offering, not a grey-market seller. You complete an eligibility assessment, a licensed clinician reviews whether a GLP-1 is appropriate, and — if so — you get a prescription alongside the Noom app's coaching curriculum. The standout feature is that the behavioral coaching isn't a bolt-on; it's Noom's entire reason for existing. That matters because the GLP-1 evidence base specifically rewards pairing the drug with behavior change. As always, "legit" and "worth it for you" are different questions.

What Noom Med actually is — and why the coaching DNA matters

Noom Med's model:

  • An eligibility assessment and clinician review — not everyone qualifies for a GLP-1, and Noom screens.
  • A prescription GLP-1 medication for eligible members (semaglutide and other GLP-1s where appropriate).
  • The Noom app's psychology-based coaching — the food logging, the behavior-change lessons, the cognitive framing Noom is known for.
  • A subscription model, with the medication cost handled separately (insurance, manufacturer cash channel, or self-pay).

The reason the coaching layer is more than marketing: the strongest GLP-1 results come from drug plus structured behavioral support. In STEP 3, semaglutide paired with intensive behavioral therapy drove larger weight loss than the drug-alone framing would predict2 — and in STEP 1, the pivotal trial, adults lost about 15% of body weight on semaglutide 2.4 mg over 68 weeks versus roughly 2.4% on placebo1. Noom is, in effect, selling its coaching as the behavioral half of that equation, with a GLP-1 as the medication half. Whether Noom's specific app adds measurable weight loss on top of the drug isn't something a testimonial can prove — but the general principle (behavioral support helps) is well grounded, and behavior change is the one thing Noom has always been about.

What Noom Med costs

As of June 2026, Noom charges a subscription for the app/coaching and, for Noom Med members, a separate medication-program cost, with the GLP-1 medication itself billed separately (insurance, the manufacturer's cash channel, or self-pay). The all-in number depends heavily on the medication side:

  • If your insurance covers the GLP-1, the app + program fee may be the main extra cost.
  • If you're self-pay, the medication dominates — brand-name Wegovy via Novo Nordisk's NovoCare has run around ~$499/month, and any compounded option carries the regulatory caveats of the post-2025 landscape (see is compounded semaglutide still legal in 2026?).

Compute the true all-in monthly cost — app subscription + program fee + medication at your dose — after any introductory discount. Our Wegovy & Ozempic cost calculator handles the medication side, and Wegovy cost and savings maps every payment route.

What people commonly report

Synthesizing recurring review themes honestly, without inventing testimonials:

  • The app is the love-it-or-hate-it part. Fans credit Noom's psychology lessons and logging for lasting habit change; critics find the daily lessons repetitive or the food-color system simplistic.
  • Billing and cancellation friction is the single most common complaint about Noom generally — the auto-renewing subscription has drawn frequent gripes, so read the cancellation terms carefully before signing up.
  • Noom Med eligibility and cost surprise some users — not everyone qualifies for a GLP-1, and the medication cost can exceed expectations if insurance doesn't cover it.
  • Results track the medication. GLP-1 users report loss consistent with the drug class, with the coaching framed as the behavioral support around it.

Treat all reviews as texture, not evidence — they are self-selected and unverified. We explain how to read GLP-1 program reviews critically in Wegovy reviews: what users and the trials report.

The honest catch

Two things to know. First, watch the subscription mechanics. Noom's auto-renewing billing is the most-cited friction point across its user base — know exactly what you're committing to and how to cancel before you start. Second, the GLP-1 weight loss is ongoing therapy. If you stop the medication, the weight tends to return — in the STEP 1 trial extension, people regained roughly two-thirds of lost weight within a year of stopping3. Noom's behavioral coaching is genuinely aimed at the maintenance problem — that's arguably its best argument — but it doesn't override the biology, and an app alone has never matched a GLP-1's loss. We cover the stopping question in what happens when you stop semaglutide and will you regain weight after stopping?.

Who Noom suits — and who should look elsewhere

Noom is a good fit if you specifically value structured, psychology-based behavior coaching alongside your GLP-1 and you'll actually use the app, and you've priced the whole thing all-in. Look elsewhere if you mainly want the cheapest legitimate path to the medication, don't want an app subscription, or are wary of auto-renewing billing — in which case NovoCare self-pay or a leaner telehealth route may cost less. We rank legitimate options on price and oversight in our independent best semaglutide providers guide and map the cheapest brand routes in best places to get Wegovy online.

The bottom line

Noom is a legitimate company whose identity is behavior-change coaching, and Noom Med layers a clinician and prescription GLP-1 on top of that app for eligible members. Its real differentiator is that the behavioral coaching — which the STEP 3 trial suggests genuinely augments GLP-1 weight loss — is Noom's whole reason for existing, not a bolt-on. It's worth it mainly for people who'll actually use and value the coaching; it's less ideal if you just want the cheapest medication or dislike subscription apps and auto-renewal. Your cost and results depend heavily on the medication side, and any GLP-1 weight loss requires ongoing therapy to maintain. For the full evidence picture, start with our pillar, Semaglutide: how it works, results and side effects; to compare legitimate options on price and oversight, see our best semaglutide providers guide. Confirm all pricing and terms with Noom directly — figures here are as of June 2026.

A few more quick ones

Is Noom semaglutide legit?

Yes. Noom is a large, well-known, legitimate company, and Noom Med is a real clinician-supervised medication offering — you complete an eligibility assessment, a licensed clinician reviews whether a GLP-1 is appropriate, and if so you get a prescription alongside the Noom app's coaching. It is not a grey-market seller. Whether it is worth the cost for you depends on the medication you get and how much you value the coaching app.

What is Noom Med?

Noom Med is Noom's medication arm. It layers a clinician review and a prescription GLP-1 medication (such as semaglutide, where appropriate) on top of Noom's psychology-based coaching app for eligible members. The standout feature is that the behavioral coaching is Noom's core identity rather than a bolt-on — and the STEP 3 trial suggests pairing a GLP-1 with structured behavioral support drives larger weight loss than the drug alone.

How much does Noom semaglutide cost?

As of June 2026, Noom charges an app/coaching subscription plus a separate medication-program cost for Noom Med, with the GLP-1 medication itself billed separately through insurance, the manufacturer's cash channel, or self-pay. The total depends heavily on the medication: if insurance covers it, the app and program fee are the main extra cost; if you self-pay, brand Wegovy via NovoCare has run around $499/month. Compute the all-in cost after any introductory discount.

Is Noom worth it for semaglutide?

It is worth it mainly for people who specifically value structured, psychology-based behavior coaching alongside their GLP-1 and will actually use the app. It is less ideal if you just want the cheapest legitimate path to the medication, don't want an app subscription, or are wary of auto-renewing billing — the most-cited complaint about Noom. In those cases, NovoCare self-pay or a leaner telehealth route may cost less.

Will the Noom coaching keep the weight off after I stop semaglutide?

Noom's behavioral coaching is genuinely aimed at the maintenance problem, which is arguably its best argument, but it does not override the biology. In the STEP 1 trial extension, people regained roughly two-thirds of lost weight within a year of stopping semaglutide, and an app alone has never matched a GLP-1's weight loss. Plan for ongoing therapy if you want to maintain the loss.

Where this comes from

Every claim above traces back to one of these — real studies and official labeling.

  1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1).. N Engl J Med. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Wadden TA, Bailey TS, Billings LK, et al. (2021). Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight (STEP 3).. JAMA. https://pubmed.ncbi.nlm.nih.gov/33625476/
  3. Wilding JPH, Batterham RL, Davies M, et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.. Diabetes Obes Metab. https://pubmed.ncbi.nlm.nih.gov/35441470/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Keep exploring